Targeting CD30 Using Brentuximab Vedotin in the Treatment of Hodgkin Lymphoma
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cancer Research,Oncology
Reference17 articles.
1. CD30 (Ki-1) molecule: a new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy.;Falini;Blood,1995
2. Brentuximab vedotin (SGN-35) for relapsed CD30-positive lymphomas.;Younes;N Engl J Med,2010
3. Results of a pivotal phase II study of brentuximab vedotin for patients with relapsed or refractory Hodgkins lymphoma.;Younes;J Clin Oncol,2012
4. Safety and efficacy of brentuximab vedotin for Hodgkin lymphoma recurring after allogeneic stem cell transplantation.;Gopal;Blood,2012
5. Brentuximab vedotin combined with ABVD or AVD for patients with newly diagnosed Hodgkins lymphoma: a phase 1, open-label, dose-escalation study.;Younes;Lancet Oncol,2013
Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Brentuximab vedotin therapy followed by autologous peripheral stem cell transplantation as a viable treatment option for an older adult with transformed lymphoma: a case report and literature review;Journal of International Medical Research;2024-06
2. Antibody and Cell-Based Therapies against Virus-Induced Cancers in the Context of HIV/AIDS;Pathogens;2023-12-22
3. Emerging predictive biomarkers for novel therapeutics in peripheral T-cell and natural killer/T-cell lymphoma;Frontiers in Immunology;2023-01-26
4. Rechute mammaire isolée d'un lymphome de Hodgkin, une présentation clinique rare: à propos d'un cas;Pan African Medical Journal;2022
5. Fibroblast Growth Factor 2 Conjugated with Monomethyl Auristatin E Inhibits Tumor Growth in a Mouse Model;Biomacromolecules;2021-09-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3